The hope of this effort is to be able to bring meaningful health data through these devices.
While wearable tech has been gradually rising in popularity, many believe that it wasn’t until the recent Apple Watch unveiling that this type of device was catapulted into the mainstream spotlight.
That said, even before that time, a team of doctors had started a new effort to make them practical for mhealth.
The wearable tech industry specifically for activity and sports trackers is expected to reach $1.4 billion within the upcoming two years . This will allow for a tremendous collection of activity data. A team of doctors feels that this presents a massive opportunity for leveraging that data to develop resources that will help people to be able to make meaningful decisions with regards to their health care. The team is working under the name Vivametrica.
Vivametrica is aiming to develop a wearable tech based analytics platform that will be a first of its kind.
This platform for wearables will be meant for enterprises, health care providers, and patients, alike. Its development is based on several years of clinical research that connects health risks with various types of activities.
The mobile wearable device being produced by Vivametrics is operating system agnostic, which means that it will be compatible with smartphones regardless of whether they run on iOS, Android, BlackBerry, Windows Phone, or any other operating system. This was because the team was seeking to take a standardized approach to the collection and management of the data. The goal was to help to span the gap that currently exists between current wearable fitness apps and actual health data upon which specific action can be taken.
The Vivametrics company has every intention of using wearable tech to be able to provide improvements in the areas of credible, personalized assessment, and research based analytics. The team is made up of health, medicine, and business experts that include: Dr. Richard Hu (the company’s CEO and founder), Dr. Christy Lane (the company’s COO and co-founder), Dr. Matthew Smuck (the company’s scientific advisor and cofounder), and Scott Valentine (the company’s president).
